Phase 2 Expansion to be complete January 2020

MJardin’s Atlantic Canada Cultivation & Extraction Facility Receives Sales Licence

“MJardin Group, Inc., a leader in premium cannabis production announced its AtlantiCann Medical Inc. (“AMI”) facility had been awarded a sales license from Health Canada. AMI is a joint venture corporation consisting of Nova Scotia Mi’kmaq First Nations (51%), MJardin Group, Inc. (39%) and the Halef Group (10%).

The license comes just weeks before phase 2 construction is set to be complete adding 20,000 square feet to the original footprint making the expanded facility 68,000 square feet with a total of 6,300 kg/year of production capacity.

On September 9, 2019, MJardin announced that the AMI facility has secured a supply contract with Franchise Cannabis Corp. subsidiary, ACA Muller for 2,250 kg of high THC (>20%) medical cannabis to serve the German market. AMI expects to receive EU GMP certification in Q4 2020.

About MJardin Group

MJardin is a cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. MJardin is based in Denver, Colorado and Toronto, Canada. For more information, please visit www.mjardin.com.”

Source: Globe News Wire